Home
Products
Learn
About
Pricing
Log In
AVEOA
Asset Logo

Avecho Biotechnology Limited

🇦🇺 ASX

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

N/A
Annual Growth

5 years average annual capital growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Avecho Biotechnology Limited - Option Expiring 10-May-2026

📈 Performance

Price History

N/A

1M

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.00

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in AVEOA

1

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in AVEOA

N/A
AVEOA investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

100%
👶 Age of investors

18 - 25

26 - 34

35 - 90

100%
🙋 Legal gender of investors

Female

100%

Male

Pearlers who invest in AVEOA also invest in...

VESG

VESG.AX was created on 2018-09-11 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Ethically Conscious International Shares Index ETF seeks to track the return of the FTSE Developed ex Australia Choice Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax

📊 Share price

$73.26 AUD

NULL GLOBAL

NULL SMART BETA

NULL ETHICAL

NULL EX AUSTRALIA

Find Out More

Avecho Biotechnology Ltd. engages in the development, production, sale, and licensing of products incorporating its patented platform technology, Targeted Penetration Matrix (TPM), for the pharmaceutical, skin care and animal health and nutrition industries. The company is headquartered in Melbourne, Victoria. The firm develops and commercializes human and animal health products using its drug delivery system Tocopherol Phosphate Mixture (TPM). The firm's products pipeline includes Weaner Pig Starter TPM premix, Poultry TPM, Dairy TPM, Daptomycin, Propofol and Veterinary Applications. The firm's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for the use in drug delivery and cosmetic formulations. The Company’s Human Health segment covers delivery of pharmaceutical products through gels, injectables and patches. This segment focuses on the development of patches, including TPM/Oxymorphone, TPM/enhanced, and TPM/Oxycodone. The firm is also developing TPM to enhance feed efficiency and health of livestock. Its TPM products are commercialized under license Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.

📊 Share price

$0.01 AUD

Lark Distilling Co. Ltd. engages in the further development of investment opportunities in the Australian craft distilling industry. The company is headquartered in Hobart, Tasmania. The company went IPO on 2003-11-12. The firm has three segments: whisky, gin and other. The company offers about 51 Whisky products, such as Dark Lark Single Malt Whisky, Classic Cask, Boilermaker House Whisky Bar Limited Release, and Para 1992 Cask Finish with 100ml Tawny Liqueur, among others. The company offers about eight Gin products, which include Forty Spotted Citrus & Pepperberry + Pinot Noir Gin, Forty Spotted Classic Gin & Raspberry + Rose, Forty Spotted Classic, Forty Spotted Tassie Bush Honey, Forty Spotted Wild Rose, Forty Spotted Citrus & Pepperberry, Forty Spotted Raspberry & Rose, and Forty Spotted Pinot Noir. The company operates in Tasmania and Australia. The company markets its products via traditional off-premise retailers and on-premises bars, and via its direct-to-consumer business, which is hospitality and online e-commerce. Its primary focus is Whisky and the Lark brand.

📊 Share price

$1.74 AUD

Clean TeQ Water Ltd. provides water purification and recycling solutions. The firm's principal activity is the provision and development of technology solutions for water treatment and water reuse and resource recovery to government entities and companies, including municipal, industrial and mining sectors. Its technology solutions include desalination, nutrient removal, zero liquid discharge and hardness removal. Its sectors of focus include municipal wastewater, surface water, industrial wastewater and mining process water. Its products include CIF (Continuous Ionic Filtration), HIROX (Ultra High Recovery Reverse Osmosi), DESALX (Membrane Free Desalination), BIOCLENS (Encapsulated Bacteria Lenses), BIONEX (Nutrient Removal), and EVAPX (Evaporation and Crystallization). The company is also engaged in developing a membrane based on graphene oxide for water and wastewater filtration. Its subsidiaries include Clean TeQ Water Operations Pty Ltd, Associated Water Pty Ltd, and NematiQ Pty Ltd.

📊 Share price

$0.28 AUD

The Hydration Pharmaceuticals Co. Ltd. markets and sells a range of liquid, tablet and powder healthy hydration solutions products. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-12-14. The firm markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the North American markets of Canada and the United States, under the Hydralyte brand. The firm operates as a wholesale supplier and online retailer of Hydralyte products in North America. The firm has its operations in Canada, United States and Australia. Its subsidiaries include Hydration Pharmaceuticals Trust, Hydration Pharmaceuticals Canada, Hydralyte LLC, Hydration Pharmaceutical Service Pty Ltd, and Hydration Therapeutics UK Limited.

📊 Share price

$0.06 AUD

Want more shares? Try these...

Australian Vintage Ltd. engages in wine making, wine marketing, and vineyard management. The company is headquartered in Adelaide, South Australia and currently employs 450 full-time employees. The principal activities of the Company are wine making, wine marketing and vineyard management company. The firm operates in three segments: Australia / New Zealand, UK, Europe & Americas and Asia. The Australia / New Zealand segment is engaged in the manufacturing, sales and marketing of wine in Australia, New Zealand and the Pacific through wholesale and retail channels. The UK, Europe & Americas segment is engaged in the packaging, sales and marketing of wine in the United Kingdom, Europe & the Americas through wholesale, distributor and retail channels. The Asia segment is engaged in the sales and marketing of wine in Asia through wholesale channels. The Company’s brands include McGuigan Wines, Tempus Two, Nepenthe, and Barossa Valley Wine Company. The McGuigan Wines volume includes #1 Black Label Red, #3 Black Label Cabernet Merlot and #6 Black Label Merlot.

📊 Share price

$0.48 AUD

📊 Share price

$0.00 AUD
Compare
Add to watchlist